经导管主动脉瓣置换术患者冠状动脉疾病的管理与处理策略  

Management and treatment strategy of coronary artery disease in patients undergoing transcatheter aortic valve replacement

作　　者：俞吉维 杜润[1] 朱政斌[1] 张瑞岩[1] YU Ji-wei;DU Run;ZHU Zheng-bin;ZHANG Rui-yan(Department of Cardiovascular Medicine,Institute of Cardiovascular Disease,Shanghai Jiaotong University School of Medicine,Shanghai 200025,China)

机构地区：[1]上海交通大学医学院附属瑞金医院心脏科,上海200025

出　　处：《中国介入心脏病学杂志》2023年第6期452-456,共5页Chinese Journal of Interventional Cardiology

摘　　要：接受经导管主动脉瓣置换术(TAVR)的患者常合并冠状动脉疾病(CAD),此外,TAVR术中可能存在冠状动脉闭塞的风险。随着TAVR适应证的扩展,对于TAVR患者CAD管理变得尤为重要。本文对TAVR患者合并冠状动脉病变的流行病学及预后、处理原则及策略,TAVR术中冠状动脉风险的评估及应对进行综述。Patients undergoing transcatheter aortic valve replacement(TAVR)often have concomitant coronary artery disease.Additionally,there is a risk of coronary artery occlusion during TAVR.With the expansion of TAVR indications,the management of coronary artery disease in TAVR patients has become increasingly important.This article provides a review of the epidemiology and prognosis of TAVR with coronary artery disease,as well as management principles,assessment of coronary risk during TAVR,and response strategies.

关 键 词：经导管主动脉瓣置换术 冠状动脉疾病 主动脉瓣狭窄 

分 类 号：R541[医药卫生—心血管疾病]